Citius Oncology (CTOR) Current Assets (2022 - 2026)
Citius Oncology (CTOR) posted quarterly Current Assets of $29.4 million for Q1 2026, up 63.11% year-over-year from $18.0 million in Q1 2025, and down 20.79% quarter-over-quarter from $37.1 million in Q4 2025.
Citius Oncology (CTOR) Current Assets (2022 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Current Assets for 5 consecutive years, with $29.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 63.11% year-over-year to $29.4 million; the TTM figure through Mar 2026 stood at $29.4 million (up 63.11% YoY), while the FY2025 annual figure was $27.5 million, up 151.1% from the prior year.
- Current Assets declined to $29.4 million in Q1 2026 per CTOR's latest filing, from $37.1 million in the prior quarter.
- Across five years, Current Assets topped out at $37.1 million in Q4 2025 and bottomed at $40988.0 in Q2 2024.
- Historically, Current Assets has averaged $12.0 million across 5 years, with a median of $9.4 million in 2023.
- Annual changes were most pronounced in 2024 — Current Assets tumbled 91.13% — and 2025, when it soared 44569.36%.
- Citius Oncology's Current Assets stood at $377344.0 in 2022, then sank by 84.58% to $58200.0 in 2023, then surged by 29249.62% to $17.1 million in 2024, then jumped by 117.47% to $37.1 million in 2025, then dropped by 20.79% to $29.4 million in 2026.
- Business Quant data shows CTOR's Current Assets at $29.4 million in Q1 2026, $37.1 million in Q4 2025, and $27.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Citius Oncology | 80.25 Mn | 80.25 Mn | 1.00 Mn | 42.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.42 Mn |
| Dec 31, 2025 | 37.15 Mn |
| Sep 30, 2025 | 27.54 Mn |
| Jun 30, 2025 | 18.31 Mn |
| Mar 31, 2025 | 18.04 Mn |
| Dec 31, 2024 | 17.08 Mn |
| Sep 30, 2024 | 10.97 Mn |
| Jun 30, 2024 | 40,988.00 |
| Mar 31, 2024 | 94,394.00 |
| Dec 31, 2023 | 58,200.00 |
| Sep 30, 2023 | 7.73 Mn |
| Jun 30, 2023 | 461,907.00 |
| Mar 31, 2023 | 245,366.00 |
| Dec 31, 2022 | 377,344.00 |